Comments
Loading...

Cosciens Biopharma

CSCINASDAQ
Logo brought to you by Benzinga Data

Cosciens Biopharma (NASDAQ:CSCI) Stock Quotes, Forecast and News Summary

Cosciens Biopharma Stock (NASDAQ: CSCI) stock price, news, charts, stock research, profile.

Open$3.04
Close-
Volume / Avg.4.55K / 8.25K
Day Range$2.97 - $3.10
52 Wk Range2.62 - 6.77
Market Cap$9.53M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest-
Days to Cover1.97

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open$3.04
Close-
Volume / Avg.4.55K / 8.25K
Day Range$2.97 - $3.10
52 Wk Range2.62 - 6.77
Market Cap$9.53M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest-
Days to Cover1.97

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CSCI

FAQ

Q

How do I buy Cosciens Biopharma (CSCI) stock?

A

You can purchase shares of Cosciens Biopharma (NASDAQ:CSCI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cosciens Biopharma (CSCI) competitors?

A

There are no as such competitors for Cosciens Biopharma.

Q

What is the forecast, or price target, for Cosciens Biopharma (CSCI) stock?

A

There is no analysis for Cosciens Biopharma to provide a consensus price target.

Q

What is the current price for Cosciens Biopharma (CSCI)?

A

The stock price for Cosciens Biopharma (NASDAQ: CSCI) is $3.39 last updated November 15, 2024 at 4:33 PM EST.

Q

Does Cosciens Biopharma (CSCI) pay a dividend?

A

There are no upcoming dividends for Cosciens Biopharma.

Q

When is Cosciens Biopharma (NASDAQ:CSCI) reporting earnings?

A

Cosciens Biopharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Q

Is Cosciens Biopharma (CSCI) going to split?

A

There is no upcoming split for Cosciens Biopharma.

Q

What sector and industry does Cosciens Biopharma (CSCI) operate in?

A

Cosciens Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.